Amphastar Pharmaceuticals's total assets for Q2 2025 were $1.62B, a decrease of -0.67% from the previous quarter. AMPH total liabilities were $857.85M for the fiscal quarter, a -1.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.